Peel Hunt reaffirmed their buy rating on shares of RS Group (LON:RS1 – Get Rating) in a research report sent to investors on Tuesday, MarketBeat Ratings reports. The firm currently has a GBX 1,100 ($13.41) price objective on the stock.
Several other analysts have also issued reports on the company. Berenberg Bank upped their price objective on RS Group from GBX 1,010 ($12.31) to GBX 1,050 ($12.80) and gave the company a hold rating in a research note on Tuesday, February 21st. Morgan Stanley started coverage on RS Group in a research note on Thursday, February 16th. They issued an equal weight rating and a GBX 950 ($11.58) price objective on the stock. Finally, Shore Capital upgraded RS Group to a hold rating in a research note on Tuesday. One research analyst has rated the stock with a sell rating, four have issued a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, RS Group presently has an average rating of Hold and an average target price of GBX 1,038.33 ($12.65).
RS Group Stock Performance
RS1 opened at GBX 922 ($11.24) on Tuesday. RS Group has a 52-week low of GBX 790 ($9.63) and a 52-week high of GBX 1,169 ($14.25). The firm has a market capitalization of £4.36 billion, a PE ratio of 1,646.43, a PEG ratio of 1.85 and a beta of 0.86. The company has a debt-to-equity ratio of 29.28, a quick ratio of 1.24 and a current ratio of 2.01. The business’s 50-day simple moving average is GBX 961.99 and its 200 day simple moving average is GBX 967.06.
About RS Group
RS Group plc, together with its subsidiaries, distributes various electronics and industrial products in the United Kingdom, the United States, France, Germany, Italy, and internationally. The company provides industrial interconnect and test, industrial automation and control, board-level electronics, and single-board computing products; and tools, consumables, and facilities maintenance products, such as personal protective equipment, site safety products, and 3D printing products.
Featured Articles
- Monoclonal Antibodies? Avid Bioservices surges 32% on Blowout Q3
- GitLab Crashes On Guidance; Analysts Defend
- Healthcare Stocks With at Least 30 Years of Dividend Increases
- Coinbase Pops As SVB Crumbles To Dust
- Airlines Update Guidance, Shares Head For Different Destinations
Receive News & Ratings for RS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RS Group and related companies with MarketBeat.com's FREE daily email newsletter.